Alpha Tau Valuation
| DRTS Stock | USD 2.53 0.21 9.05% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Alpha Tau Medical shows a prevailing Real Value of $5.62 per share. The current price of the firm is $2.53. Our model approximates the value of Alpha Tau Medical from analyzing the firm fundamentals such as Current Valuation of 109.98 M, return on equity of -0.33, and Shares Owned By Insiders of 25.56 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Alpha Tau's valuation include:
Price Book 2.3436 | Enterprise Value 110 M | Enterprise Value Ebitda (4.77) |
Undervalued
Today
Please note that Alpha Tau's price fluctuation is slightly risky at this time. Calculation of the real value of Alpha Tau Medical is based on 3 months time horizon. Increasing Alpha Tau's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Alpha stock is determined by what a typical buyer is willing to pay for full or partial control of Alpha Tau Medical. Since Alpha Tau is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alpha Stock. However, Alpha Tau's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.53 | Real 5.62 | Target 15.0 | Hype 2.52 | Naive 2.42 |
The intrinsic value of Alpha Tau's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alpha Tau's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alpha Tau Medical helps investors to forecast how Alpha stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alpha Tau more accurately as focusing exclusively on Alpha Tau's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alpha Tau's intrinsic value based on its ongoing forecasts of Alpha Tau's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alpha Tau's closest peers.
Alpha Tau Cash |
|
Alpha Valuation Trend
Alpha Tau's real value is important for investors to make better decisions and a more accurate overall view of Alpha Tau's financial worth over time. Using both Alpha Tau's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Alpha Tau Total Value Analysis
Alpha Tau Medical is currently anticipated to have valuation of 109.98 M with market capitalization of 162.64 M, debt of 13.28 M, and cash on hands of 112.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alpha Tau fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
109.98 M | 162.64 M | 13.28 M | 112.04 M |
Alpha Tau Asset Utilization
One of the ways to look at asset utilization of Alpha is to check how much profit was generated for every dollar of assets it reports. Alpha Tau Medical shows a negative utilization of assets of -0.22 percent, losing $0.002192 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Alpha Tau Medical shows how discouraging it operates for each dollar spent on its assets.Alpha Tau Ownership Allocation
Alpha Tau holds a total of 70.1 Million outstanding shares. Alpha Tau Medical retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alpha Tau Profitability Analysis
Net Loss for the year was (29.16 M) with profit before overhead, payroll, taxes, and interest of 0.About Alpha Tau Valuation
The stock valuation mechanism determines Alpha Tau's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Alpha Tau Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alpha Tau. We calculate exposure to Alpha Tau's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alpha Tau's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.1 M | -1.1 M |
Alpha Tau Growth Indicators
Investing in growth stocks can be very risky. If the company such as Alpha Tau does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 69.4 M |
Alpha Tau Current Valuation Indicators
Alpha Tau's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alpha Tau's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alpha Tau, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alpha Tau's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alpha Tau's worth.Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.